| Health Care Equipment & Supplies Industry | Healthcare Sector | Ivan Tornos CEO | B3 Exchange | - ISIN |
| US Country | 17,000 Employees | 25 Jun 2025 Last Dividend | - Last Split | 25 Jul 2001 IPO Date |
Zimmer Biomet Holdings, Inc., alongside its subsidiaries, is entrenched in the musculoskeletal healthcare sector, spreading its influence across the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The enterprise is committed to designing, manufacturing, and marketing a comprehensive range of orthopaedic reconstructive products. Initially known as Zimmer Holdings, Inc., the organization underwent a rebranding to Zimmer Biomet Holdings, Inc. in June 2015, marking a significant milestone in its evolution since its inception in 1927. This rebranding reflects the company’s growth and its expanding portfolio in the musculoskeletal healthcare domain. Headquartered in Warsaw, Indiana, Zimmer Biomet has become a pivotal player in providing solutions for patients afflicted with disorders or injuries related to bones, joints, or supporting soft tissues. It caters to the needs of orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, and a broad spectrum of healthcare professionals and organizations worldwide.
Zimmer Biomet Holdings, Inc. offers a wide variety of products and services across several key areas in musculoskeletal healthcare: